Literature DB >> 16395754

Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies.

Jean-David Cohen1, Patrick Cunin, Valérie Farrenq, Owanoyo Oniankitan, Laurence Carton, Xavier Chevalier, Pascal Claudepierre.   

Abstract

OBJECTIVE: To estimate the best Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) cutoff based on patients' perceptions of symptom relief collected in a large population of patients with spondyloarthropathies (SpA), in comparison to the BASDAI cutoff determined by experts.
METHODS: A survey of patient perceptions about current disease control was conducted among the members of Spondylis, one of the main not-for-profit SpA patient organizations in France. BASDAI was among data collected by the questionnaire. To estimate the best BASDAI cutoff for discriminating between poor and well perceived controlled groups, we plotted the receiver operating characteristic (ROC) curve. We also determined the cutoff separately in male and female patients.
RESULTS: Of the 1000 mailed questionnaires, 485 were returned without any missing data regarding perceived disease control and the BASDAI. Of these patients, 55.3% perceived inadequate control of their disease. The mean BASDAI in the overall population was 43.5 +/- 22.9, 30.4 +/- 19.9 in the well controlled group and 54 +/- 19.4 in the poorly controlled group (p < 0.001). The best BASDAI cutoff for discriminating between patients in the 2 groups was 39 (sensitivity 74.6% and specificity 72.4%). According to gender, the best cutoff was 44 for women and 36 for men.
CONCLUSION: The best BASDAI cutoff of 39 based on patients' perceptions was very similar to that selected by international experts, i.e., 40. Gender affected the cutoff for perceived symptom relief in our study. These results need to be confirmed by further studies collecting the opinions of both patients and physicians.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395754

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Prevalence of Temporomandibular Joint Disorders in Patients with Ankylosing Spondylitis: A Cross-Sectional Study.

Authors:  Rebeca Cecília Souza; Emerson Tavares de Sousa; David Sousa; Marcelo Sales; Rudyard Dos Santos Oliveira; Maria Helena Mariano; Eliézer Rushansky; Ana Cláudia Amorim Gomes; Emanuel Silva
Journal:  Clin Cosmet Investig Dent       Date:  2021-11-11

Review 2.  Exercise programmes for ankylosing spondylitis.

Authors:  Jean-Philippe Regnaux; Thomas Davergne; Clémence Palazzo; Alexandra Roren; François Rannou; Isabelle Boutron; Marie-Martine Lefevre-Colau
Journal:  Cochrane Database Syst Rev       Date:  2019-10-02

3.  Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis.

Authors:  Isabel Castrejón; Theodore Pincus; Daniel Wendling; Maxime Dougados
Journal:  RMD Open       Date:  2016-07-07

4.  Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis.

Authors:  Fariz Yahya; Karl Gaffney; Raj Sengupta
Journal:  Rheumatol Adv Pract       Date:  2019-05-04

5.  Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen-B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Authors:  Philip J Mease; Soumya D Chakravarty; Robert R McLean; Taylor Blachley; Toana Kawashima; Iris Lin; Arthur Kavanaugh; Alexis Ogdie
Journal:  ACR Open Rheumatol       Date:  2022-02-26

Review 6.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

7.  Hip involvement in children with enthesitis related arthritis (ERA) is associated with poor outcomes in adulthood.

Authors:  R Naveen; Namita Mohindra; Neeraj Jain; Sanjukta Majumder; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2021-06-25       Impact factor: 2.980

8.  Gastrointestinal risk factors and patient-reported outcomes of ankylosing spondylitis in Korea.

Authors:  Sang-Hoon Lee; Yong-Wook Park; Jung-Yoon Choe; Kichul Shin; Seong-Ryul Kwon; Jin-Hye Cha; Young-Joo Kim; Juneyoung Lee; Tae-Hwan Kim
Journal:  Int J Rheum Dis       Date:  2019-12-29       Impact factor: 2.454

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.